BCAL Diagnostics

BCAL Diagnostics Debt

The Debt of BCAL Diagnostics (BDX.AX) as of Oct 18, 2026 is 2.38 M AUD. In the previous year, Debt was 1.52 M AUD — a change of 56.11% (higher).

Debt

2.38 MAUD

YoY

56.11%

Last updated:

In 2025, BCAL Diagnostics's total debt was 2.38 M AUD, a 56.11% change from the 1.52 M AUD total debt recorded in the previous year.

The BCAL Diagnostics Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2018
500,000.00 AUD
Jan 1, 2019
0.00 AUD
Jan 1, 2020
300,000.00 AUD
Jan 1, 2021
0.00 AUD
Jan 1, 2022
0.00 AUD
Jan 1, 2023
1.06 M AUD
Jan 1, 2024
1.52 M AUD
Jan 1, 2025
2.38 M AUD
The BCAL Diagnostics Debt history
YEARDebtYoY
2.38 MAUD+56.11%
1.52 MAUD+43.57%
1.06 MAUD—
0.00AUD—
0.00AUD-100.00%
300,000.00AUD—
0.00AUD-100.00%
500,000.00AUD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

BCAL Diagnostics Stock analysis

What does BCAL Diagnostics do? BCAL Diagnostics Ltd, based in Sydney, Australia, operates in the Health Care sector within the Biotechnology industry. The company develops innovative blood screening tests for early breast cancer detection, focusing on a lipid biomarker-based approach known as the BCAL test. This technology complements existing imaging methods like mammograms and aims to support screening and monitoring for women of all ages and backgrounds. BCAL Diagnostics has partnered with Precion Inc. to advance clinical trials and regulatory approvals for its diagnostic solutions. BCAL Diagnostics is one of the most popular companies on Eulerpool.

Debt Details

Understanding BCAL Diagnostics's Debt Structure

BCAL Diagnostics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing BCAL Diagnostics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to BCAL Diagnostics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in BCAL Diagnostics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about BCAL Diagnostics stock

Debt of BCAL Diagnostics is 2.38 M AUD in 2025.

Debt of BCAL Diagnostics changed from 1.52 M AUD to 2.38 M AUD, representing a 56.11% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Debt BCAL Diagnostics since 2006 – with annual values, charts, and detailed analysis.

Debt's AUD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's BCAL Diagnostics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — BCAL Diagnostics

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — BCAL Diagnostics